Search

Strontium (Sr) is an element of toxicological concern due to its close chemical proximity to Ca. In this work, Sr in sea salts collected from China and South Korea was analyzed by laser‐induced breakdown spectroscopy (LIBS). The precision could be improved by using multiple filter‐paper sampling and intensity normalization using a weak Na I line as a reference signal. The analyte signal variation between filter‐paper pieces as well as that within a single filter‐paper piece could be corrected by the suggested method. The limit of detection of ~2 ppm and the precision of ~5% could be obtained. As a measure of accuracy, the root‐mean‐square error was estimated to be 9 ppm. The multiple filter‐paper sampling can be performed easily on the salt production sites and improves the LIBS analysis precision resulting to sufficient quantification capability for minor metallic elements in edible sea salt products. [ABSTRACT FROM AUTHOR]

The discipline of marriage and family therapy (MFT) has been established around the world. Inspired by theories and models developed in Western countries, professionals in East Asian countries over the last two decades have been dedicated to introducing the concepts of MFT to local mental health professionals. This paper presents an overview of the cultural background of East Asian cultures, a summary of MFT development in East Asia, and a discussion of key challenges to advancing MFT in East Asia. We provide recommendations to overcome these obstacles, including bridging the gap between MFTs in the West and East Asia, developing country‐specific MFT development plans, establishing accreditation and licensing regulation, increasing the public awareness of MFT, increasing collaboration among training institutes and the number of qualified MFT trainers and training locations, and developing culturally attuned MFT training and practices. Practitioner points: Direct application of Western approaches to the East Asian context can be detrimental if therapists do not carefully examine the cultural differences and adapt accordinglyA critical step in developing MFT in East Asia is to develop country/region‐specific plans including the recognition of the history, values, and distinctive features of Asian families [ABSTRACT FROM AUTHOR]

Aims: This paper presents updated prevalence estimates of awareness, ever‐use, and current use of nicotine vaping products (NVPs) from 14 International Tobacco Control Policy Evaluation Project (ITC Project) countries that have varying regulations governing NVP sales and marketing. Design, Setting, Participants and Measurements: A cross‐sectional analysis of adult (≥ 18 years) current smokers and ex‐smokers from 14 countries participating in the ITC Project. Data from the most recent survey questionnaire for each country were included, which spanned the period 2013–17. Countries were categorized into four groups based on regulations governing NVP sales and marketing (allowable or not), and level of enforcement (strict or weak where NVPs are not permitted to be sold): (1) most restrictive policies (MRPs), not legal to be sold or marketed with strict enforcement: Australia, Brazil, Uruguay; (2) restrictive policies (RPs), not approved for sale or marketing with weak enforcement: Canada, Malaysia, Mexico, New Zealand; (3) less restrictive policies (LRPs), legal to be sold and marketed with regulations: England, the Netherlands, Republic of Korea, United States; and (4) no regulatory policies (NRPs), Bangladesh, China, Zambia. Countries were also grouped by World Bank Income Classifications. Country‐specific weighted logistic regression models estimated adjusted NVP prevalence estimates for: awareness, ever/current use, and frequency of use (daily versus non‐daily). Findings NVP awareness and use were lowest in NRP countries. Generally, ever‐ and current use of NVPs were lower in MRP countries (ever‐use = 7.1–48.9%; current use = 0.3–3.5%) relative to LRP countries (ever‐use = 38.9–66.6%; current use = 5.5–17.2%) and RP countries (ever‐use = 10.0–62.4%; current use = 1.4–15.5%). NVP use was highest among high‐income countries, followed by upper–middle‐income countries, and then by lower–middle‐income countries. Conclusions: With a few exceptions, awareness and use of nicotine vaping products varied by the strength of national regulations governing nicotine vaping product sales/marketing, and by country income. In countries with no regulatory policies, use rates were very low, suggesting that there was little availability, marketing and/or interest in nicotine vaping products in these countries where smoking populations are predominantly poorer. The higher awareness and use of nicotine vaping products in high income countries with moderately (e.g. Canada, New Zealand) and less (e.g. England, United States) restrictive policies, is likely due to the greater availability and affordability of nicotine vaping products. [ABSTRACT FROM AUTHOR]

Please cite this paper as: Belshe et al. (2010). Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age. Influenza and Other Respiratory Viruses 4(3), 141–145. Background It has been suggested that live attenuated influenza vaccine (LAIV) may be less effective in older individuals because of prior wild-type influenza infections. LAIV is currently approved in the United States, South Korea and Hong Kong for individuals 2–49 years of age. Objective To examine data from previously published pediatric studies to determine the efficacy of LAIV in various age groups. Methods Four studies in which the subject age range exceeded 36 months were identified: one 2-year study comparing LAIV with placebo and three 1-year studies comparing LAIV with trivalent inactivated influenza vaccine (TIV). Efficacy against any strain regardless of antigenic similarity to vaccine was analyzed by age; age groups were based on the study design and sample size. A logistic regression model was used to assess whether age, as a continuous variable, was an effect modifier on LAIV efficacy. Results The efficacy of LAIV did not vary with age in children aged 15–84 months compared with placebo or in children aged 6 months to 17 years compared with TIV. Conclusions The available data from prospective, randomized studies in children does not support the concept that prior repeated exposure to influenza, either through wild-type infection or vaccination with live, attenuated or inactivated vaccines, reduces the efficacy of LAIV compared with placebo or TIV. The decreased immunologic responses to LAIV reported in older individuals or those with pre-existing immunity do not appear to translate into reduced protection from influenza in children. [ABSTRACT FROM AUTHOR]